Drug Repositioning and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Drug Repositioning Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Repositioning Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Repositioning Overall Market Size
2.1 Global Drug Repositioning Market Size: 2021 VS 2028
2.2 Global Drug Repositioning Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Repositioning Players in Global Market
3.2 Top Global Drug Repositioning Companies Ranked by Revenue
3.3 Global Drug Repositioning Revenue by Companies
3.4 Top 3 and Top 5 Drug Repositioning Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drug Repositioning Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Repositioning Players in Global Market
3.6.1 List of Global Tier 1 Drug Repositioning Companies
3.6.2 List of Global Tier 2 and Tier 3 Drug Repositioning Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drug Repositioning Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Intravenous
4.2 By Type - Global Drug Repositioning Revenue & Forecasts
4.2.1 By Type - Global Drug Repositioning Revenue, 2017-2022
4.2.2 By Type - Global Drug Repositioning Revenue, 2023-2028
4.2.3 By Type - Global Drug Repositioning Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drug Repositioning Market Size, 2021 & 2028
5.1.2 Central Nervous Disorders
5.1.3 Cardiovascular Disorders
5.1.4 Oncology
5.1.5 Others
5.2 By Application - Global Drug Repositioning Revenue & Forecasts
5.2.1 By Application - Global Drug Repositioning Revenue, 2017-2022
5.2.2 By Application - Global Drug Repositioning Revenue, 2023-2028
5.2.3 By Application - Global Drug Repositioning Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Drug Repositioning Market Size, 2021 & 2028
6.2 By Region - Global Drug Repositioning Revenue & Forecasts
6.2.1 By Region - Global Drug Repositioning Revenue, 2017-2022
6.2.2 By Region - Global Drug Repositioning Revenue, 2023-2028
6.2.3 By Region - Global Drug Repositioning Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Drug Repositioning Revenue, 2017-2028
6.3.2 US Drug Repositioning Market Size, 2017-2028
6.3.3 Canada Drug Repositioning Market Size, 2017-2028
6.3.4 Mexico Drug Repositioning Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Drug Repositioning Revenue, 2017-2028
6.4.2 Germany Drug Repositioning Market Size, 2017-2028
6.4.3 France Drug Repositioning Market Size, 2017-2028
6.4.4 U.K. Drug Repositioning Market Size, 2017-2028
6.4.5 Italy Drug Repositioning Market Size, 2017-2028
6.4.6 Russia Drug Repositioning Market Size, 2017-2028
6.4.7 Nordic Countries Drug Repositioning Market Size, 2017-2028
6.4.8 Benelux Drug Repositioning Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Drug Repositioning Revenue, 2017-2028
6.5.2 China Drug Repositioning Market Size, 2017-2028
6.5.3 Japan Drug Repositioning Market Size, 2017-2028
6.5.4 South Korea Drug Repositioning Market Size, 2017-2028
6.5.5 Southeast Asia Drug Repositioning Market Size, 2017-2028
6.5.6 India Drug Repositioning Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Drug Repositioning Revenue, 2017-2028
6.6.2 Brazil Drug Repositioning Market Size, 2017-2028
6.6.3 Argentina Drug Repositioning Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drug Repositioning Revenue, 2017-2028
6.7.2 Turkey Drug Repositioning Market Size, 2017-2028
6.7.3 Israel Drug Repositioning Market Size, 2017-2028
6.7.4 Saudi Arabia Drug Repositioning Market Size, 2017-2028
6.7.5 UAE Drug Repositioning Market Size, 2017-2028
7 Players Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Drug Repositioning Major Product Offerings
7.1.4 Novartis AG Drug Repositioning Revenue in Global Market (2017-2022)
7.1.5 Novartis AG Key News
7.2 Abbott Healthcare
7.2.1 Abbott Healthcare Corporate Summary
7.2.2 Abbott Healthcare Business Overview
7.2.3 Abbott Healthcare Drug Repositioning Major Product Offerings
7.2.4 Abbott Healthcare Drug Repositioning Revenue in Global Market (2017-2022)
7.2.5 Abbott Healthcare Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Drug Repositioning Major Product Offerings
7.3.4 Pfizer Drug Repositioning Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Drug Repositioning Major Product Offerings
7.4.4 Johnson & Johnson Drug Repositioning Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Hoffmann-La Roche
7.5.1 Hoffmann-La Roche Corporate Summary
7.5.2 Hoffmann-La Roche Business Overview
7.5.3 Hoffmann-La Roche Drug Repositioning Major Product Offerings
7.5.4 Hoffmann-La Roche Drug Repositioning Revenue in Global Market (2017-2022)
7.5.5 Hoffmann-La Roche Key News
7.6 Sandoz
7.6.1 Sandoz Corporate Summary
7.6.2 Sandoz Business Overview
7.6.3 Sandoz Drug Repositioning Major Product Offerings
7.6.4 Sandoz Drug Repositioning Revenue in Global Market (2017-2022)
7.6.5 Sandoz Key News
7.7 Mylan Inc.
7.7.1 Mylan Inc. Corporate Summary
7.7.2 Mylan Inc. Business Overview
7.7.3 Mylan Inc. Drug Repositioning Major Product Offerings
7.7.4 Mylan Inc. Drug Repositioning Revenue in Global Market (2017-2022)
7.7.5 Mylan Inc. Key News
7.8 Teva Pharmaceuticals
7.8.1 Teva Pharmaceuticals Corporate Summary
7.8.2 Teva Pharmaceuticals Business Overview
7.8.3 Teva Pharmaceuticals Drug Repositioning Major Product Offerings
7.8.4 Teva Pharmaceuticals Drug Repositioning Revenue in Global Market (2017-2022)
7.8.5 Teva Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Drug Repositioning Market Opportunities & Trends in Global Market
Table 2. Drug Repositioning Market Drivers in Global Market
Table 3. Drug Repositioning Market Restraints in Global Market
Table 4. Key Players of Drug Repositioning in Global Market
Table 5. Top Drug Repositioning Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drug Repositioning Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drug Repositioning Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drug Repositioning Product Type
Table 9. List of Global Tier 1 Drug Repositioning Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Repositioning Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Drug Repositioning Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drug Repositioning Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drug Repositioning Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Drug Repositioning Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drug Repositioning Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drug Repositioning Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Drug Repositioning Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drug Repositioning Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drug Repositioning Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drug Repositioning Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drug Repositioning Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drug Repositioning Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drug Repositioning Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drug Repositioning Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drug Repositioning Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drug Repositioning Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drug Repositioning Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drug Repositioning Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drug Repositioning Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Drug Repositioning Product Offerings
Table 32. Novartis AG Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Healthcare Corporate Summary
Table 34. Abbott Healthcare Drug Repositioning Product Offerings
Table 35. Abbott Healthcare Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Drug Repositioning Product Offerings
Table 38. Pfizer Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Drug Repositioning Product Offerings
Table 41. Johnson & Johnson Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 42. Hoffmann-La Roche Corporate Summary
Table 43. Hoffmann-La Roche Drug Repositioning Product Offerings
Table 44. Hoffmann-La Roche Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 45. Sandoz Corporate Summary
Table 46. Sandoz Drug Repositioning Product Offerings
Table 47. Sandoz Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 48. Mylan Inc. Corporate Summary
Table 49. Mylan Inc. Drug Repositioning Product Offerings
Table 50. Mylan Inc. Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 51. Teva Pharmaceuticals Corporate Summary
Table 52. Teva Pharmaceuticals Drug Repositioning Product Offerings
Table 53. Teva Pharmaceuticals Drug Repositioning Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Drug Repositioning Segment by Type in 2021
Figure 2. Drug Repositioning Segment by Application in 2021
Figure 3. Global Drug Repositioning Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drug Repositioning Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drug Repositioning Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drug Repositioning Revenue in 2021
Figure 8. By Type - Global Drug Repositioning Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drug Repositioning Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drug Repositioning Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drug Repositioning Revenue Market Share, 2017-2028
Figure 12. US Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drug Repositioning Revenue Market Share, 2017-2028
Figure 16. Germany Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 17. France Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drug Repositioning Revenue Market Share, 2017-2028
Figure 24. China Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 28. India Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drug Repositioning Revenue Market Share, 2017-2028
Figure 30. Brazil Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drug Repositioning Revenue Market Share, 2017-2028
Figure 33. Turkey Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Healthcare Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Hoffmann-La Roche Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sandoz Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mylan Inc. Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Pharmaceuticals Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
